Auto-Injectors Market by Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis), Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), Application, End-user - Global Forecast 2024-2030
Description
Auto-Injectors Market by Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis), Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), Application, End-user - Global Forecast 2024-2030
The Auto-Injectors Market size was estimated at USD 67.39 billion in 2023 and expected to reach USD 80.62 billion in 2024, at a CAGR 19.72% to reach USD 237.70 billion by 2030.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Auto-Injectors Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Auto-Injectors Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Auto-Injectors Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Antares Pharma, Inc., AstraZeneca PLC, Bayer AG, Becton, Dickinson and Company, Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Harro Höfliger Verpackungsmaschinen GmbH, Johnson & Johnson Services, Inc., Medeca Pharma AB, Merck KGaA, Mylan N.V. by Viatris Inc., NEMERA Group, Novartis AG, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SHL Medical AG, Stevanato Group, and Teva Pharmaceutical Industries Ltd..
Market Segmentation & Coverage
This research report categorizes the Auto-Injectors Market to forecast the revenues and analyze trends in each of the following sub-markets:
Therapy
Anaphylaxis
Disposable Auto-Injectors
Empty
Anaphylaxis
Ambulatory Surgical Centers
Americas
Argentina
California
Australia
Denmark
The report offers valuable insights on the following aspects:
- Market Penetration: It presents comprehensive information on the market provided by key players.
- Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
- Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
- Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
- Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
- What is the market size and forecast of the Auto-Injectors Market?
- Which products, segments, applications, and areas should one consider investing in over the forecast period in the Auto-Injectors Market?
- What are the technology trends and regulatory frameworks in the Auto-Injectors Market?
- What is the market share of the leading vendors in the Auto-Injectors Market?
- Which modes and strategic moves are suitable for entering the Auto-Injectors Market?
Note: PDF & Excel + Online Access - 1 Year
Table of Contents
189 Pages
- 1. Preface
- 1.1. Objectives of the Study
- 1.2. Market Segmentation & Coverage
- 1.3. Years Considered for the Study
- 1.4. Currency & Pricing
- 1.5. Language
- 1.6. Limitations
- 1.7. Assumptions
- 1.8. Stakeholders
- 2. Research Methodology
- 2.1. Define: Research Objective
- 2.2. Determine: Research Design
- 2.3. Prepare: Research Instrument
- 2.4. Collect: Data Source
- 2.5. Analyze: Data Interpretation
- 2.6. Formulate: Data Verification
- 2.7. Publish: Research Report
- 2.8. Repeat: Report Update
- 3. Executive Summary
- 4. Market Overview
- 4.1. Introduction
- 4.2. Auto-Injectors Market, by Region
- 5. Market Insights
- 5.1. Market Dynamics
- 5.1.1. Drivers
- 5.1.1.1. Rising prevalence of anaphylaxis among population
- 5.1.1.2. Growing inclination towards self-administration of injections
- 5.1.1.3. Widespread availability through online pharmacy channels
- 5.1.2. Restraints
- 5.1.2.1. Issues pertaining to the safety and usability of auto-injectors devices
- 5.1.3. Opportunities
- 5.1.3.1. Improvement in auto injector designs and technology
- 5.1.3.2. Increasing penetration of home-care health services
- 5.1.4. Challenges
- 5.1.4.1. Stringent regulatory and approval requirements
- 5.2. Market Segmentation Analysis
- 5.3. Market Trend Analysis
- 5.4. Cumulative Impact of High Inflation
- 5.5. Porter’s Five Forces Analysis
- 5.5.1. Threat of New Entrants
- 5.5.2. Threat of Substitutes
- 5.5.3. Bargaining Power of Customers
- 5.5.4. Bargaining Power of Suppliers
- 5.5.5. Industry Rivalry
- 5.6. Value Chain & Critical Path Analysis
- 5.7. Regulatory Framework
- 6. Auto-Injectors Market, by Therapy
- 6.1. Introduction
- 6.2. Anaphylaxis
- 6.3. Diabetes
- 6.4. Multiple Sclerosis
- 6.5. Rheumatoid Arthritis
- 7. Auto-Injectors Market, by Product Type
- 7.1. Introduction
- 7.2. Disposable Auto-Injectors
- 7.3. Reusable Auto-Injectors
- 7.4.1. Empty
- 7.4.2. Prefilled
- 8. Auto-Injectors Market, by Application
- 8.1. Introduction
- 8.2. Anaphylaxis
- 8.3. Anemia
- 8.4. Cardiovascular Diseases
- 8.5. Diabetes
- 8.6. Migraines
- 8.7. Multiple Sclerosis
- 8.8. Psoriasis
- 8.9. Rheumatoid Arthritis
- 9. Auto-Injectors Market, by End-user
- 9.1. Introduction
- 9.2. Ambulatory Surgical Centers
- 9.3. Homecare Settings
- 9.4. Hospitals & Clinics
- 10. Americas Auto-Injectors Market
- 10.1. Introduction
- 10.2. Argentina
- 10.3. Brazil
- 10.4. Canada
- 10.5. Mexico
- 10.6. United States
- 11. Asia-Pacific Auto-Injectors Market
- 11.1. Introduction
- 11.2. Australia
- 11.3. China
- 11.4. India
- 11.5. Indonesia
- 11.6. Japan
- 11.7. Malaysia
- 11.8. Philippines
- 11.9. Singapore
- 11.10. South Korea
- 11.11. Taiwan
- 11.12. Thailand
- 11.13. Vietnam
- 12. Europe, Middle East & Africa Auto-Injectors Market
- 12.1. Introduction
- 12.2. Denmark
- 12.3. Egypt
- 12.4. Finland
- 12.5. France
- 12.6. Germany
- 12.7. Israel
- 12.8. Italy
- 12.9. Netherlands
- 12.10. Nigeria
- 12.11. Norway
- 12.12. Poland
- 12.13. Qatar
- 12.14. Russia
- 12.15. Saudi Arabia
- 12.16. South Africa
- 12.17. Spain
- 12.18. Sweden
- 12.19. Switzerland
- 12.20. Turkey
- 12.21. United Arab Emirates
- 12.22. United Kingdom
- 13. Competitive Landscape
- 13.1. FPNV Positioning Matrix
- 13.2. Market Share Analysis, By Key Player
- 13.3. Competitive Scenario Analysis, By Key Player
- 14. Competitive Portfolio
- 14.1. Key Company Profiles
- 14.1.1. AbbVie Inc.
- 14.1.2. Amgen Inc.
- 14.1.3. Antares Pharma, Inc.
- 14.1.4. AstraZeneca PLC
- 14.1.5. Bayer AG
- 14.1.6. Becton, Dickinson and Company
- 14.1.7. Biogen Inc.
- 14.1.8. Bristol-Myers Squibb Company
- 14.1.9. Eli Lilly and Company
- 14.1.10. F. Hoffmann-La Roche Ltd.
- 14.1.11. GlaxoSmithKline PLC
- 14.1.12. Harro Höfliger Verpackungsmaschinen GmbH
- 14.1.13. Johnson & Johnson Services, Inc.
- 14.1.14. Medeca Pharma AB
- 14.1.15. Merck KGaA
- 14.1.16. Mylan N.V. by Viatris Inc.
- 14.1.17. NEMERA Group
- 14.1.18. Novartis AG
- 14.1.19. Pfizer, Inc.
- 14.1.20. Ravimed Sp. z o.o.
- 14.1.21. Recipharm AB
- 14.1.22. Sanofi S.A.
- 14.1.23. SHL Medical AG
- 14.1.24. Stevanato Group
- 14.1.25. Teva Pharmaceutical Industries Ltd.
- 14.2. Key Product Portfolio
- 15. Appendix
- 15.1. Discussion Guide
- 15.2. License & Pricing
- FIGURE 1. AUTO-INJECTORS MARKET RESEARCH PROCESS
- FIGURE 2. AUTO-INJECTORS MARKET SIZE, 2023 VS 2030
- FIGURE 3. AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
- FIGURE 4. AUTO-INJECTORS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
- FIGURE 5. AUTO-INJECTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 6. AUTO-INJECTORS MARKET DYNAMICS
- FIGURE 7. AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
- FIGURE 8. AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 9. AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
- FIGURE 10. AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 11. AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
- FIGURE 12. AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 13. AUTO-INJECTORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
- FIGURE 14. AUTO-INJECTORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 15. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 16. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 17. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
- FIGURE 18. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 19. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 20. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
- FIGURE 22. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
- FIGURE 23. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2023
- FIGURE 24. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2023
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
